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Abstract
Background: MMTV-Cre mouse lines have played important roles in our understanding about the functions of numerous
genes in mouse mammary epithelial cells during mammary gland development and tumorigenesis. However, numerous
studies have not included MMTV-Cre mice as controls, and many investigators have not indicated which of the different
MMTV-Cre founder lines were used in their studies. Here, we describe a lactation defect that severely limits the use of one of
the most commonly used MMTV-Cre founder lines.
Methodology/Principal Findings: To explore the role of protein tyrosine phosphatase Shp1 in mammary gland
development, mice bearing the floxed Shp1 gene were crossed with MMTV-Cre mice and mammary gland development
was examined by histological and biochemical techniques, while lactation competency was assessed by monitoring pup
growth. Surprisingly, both the Shp1fl/+;MMTV-Cre and MMTV-Cre female mice displayed a severe lactation defect when
compared to the Shp1 fl/+ control mice. Histological and biochemical analyses reveal that female mice expressing the
MMTV-Cre transgene, either alone or in combination with floxed genes, exhibit defects in lobuloalveolar expansion,
presence of large cytoplasmic lipid droplets in luminal alveolar epithelial cells postpartum, and precocious induction of
involution. Using a PCR-based genotyping method, the three different founder lines can be distinguished, and we
determined that the MMTV-Cre line A, the most widely used MMTV-Cre founder line, exhibits a profound lactation defect
that limits its use in studies on mammary gland development.
Conclusions/Significance: The identification of a lactation defect in the MMTV-Cre line A mice indicates that investigators
must use MMTV-Cre alone mice as control in studies that utilize Cre recombinase to excise genes of interest from mammary
epithelial cells. Our results also suggest that previous results obtained in studies using the MMTV-Cre line A line should be
re-evaluated if the controls did not include mice expressing only Cre recombinase.
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Introduction
The ability to excise specific genes in a tissue-specific manner
has offered a great advance in our ability to determine the roles
that specific genes play in development and diseases such as cancer
at the level of the whole animal [1,2]. The current technology
involves the excision of a gene locus that is flanked by loxp sites
(floxed) through the expression of bacterial-derived Cre recombi-
nase in an organ or cell-specific manner through the use of tissue-
specific promoters [3]. The wide use of this technology requires
the generation of numerous transgenic mouse lines in which the
Cre recombinase gene is expressed under the control of different
tissue specific promoters; the current mouse database from The
Jackson Laboratories lists 268 unique entries for transgenic mice
expressing Cre recombinase (www.jax.org) demonstrating the
widespread interest in the use of this technology. These
Cre-expressing strains play important roles in understanding the
functions of genes in normal developmental processes and
neoplastic progression. Although many studies involving tissue
specific deletion of genes using the Cre-loxp recombination
technology have analyzed control mice that express Cre
recombinase in the absence of floxed genes, there are numerous
published studies in which the only control animals used were
those homozygous for the presence of the floxed alleles, and the
Cre-expressing mice were not used as control animals even though
toxic effects of Cre have been observed when it is expressed in
mammalian cells alone [4].
Analysis of the contribution of specific genes in mammary gland
development and tumorigenesis has been aided by the use of tissue
specific promoters to overexpress genes of interest in the
mammary gland, and these promoter systems have been extended
to the tissue-specific expression of Cre recombinase. Three
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on the mammary gland including MMTV-Cre (mouse mammary
tumor virus ) [5,6,7,8], WAP-Cre (whey acidic protein) [5], and
BLG-Cre (beta-lactoglobulin) [9]. The most recent development
has been bicistronic constructs that express both the Neu oncogene
and Cre recombinase, MMTV-NIC, which allows for excision of
genes of interest in cells that also express the Neu oncogene [10].
Although each of these promoter systems has distinct advantages
with regard to tissue-specificity and the temporal pattern of
expression, the MMTV-Cre mice, particularly those developed by
the Hennighausen laboratory [5,6], have been perhaps the most
extensively used Cre-expressing transgenic mouse lines with regard
to the mammary gland. Differences in the pattern of Cre
expression have been observed in three different founder lines
(A, D, and F) of the MMTV-Cre mice generated by the
Hennighausen laboratory. However, in many published papers,
investigators have not specifically mentioned which of these
different MMTV-Cre mouse lines were used in their studies.
Importantly, mammary gland development in these different
MMTV-Cre mouse lines during pregnancy and lactation has
never been carefully described. We have uncovered a lactation
defect in one of the MMTV-Cre founder lines during our study of
the effect of the SH2-domain containing protein tyrosine
phosphatase1 (Shp1) upon mammary gland development.
Shp1 plays an important role in negatively regulating the
growth and differentiation of various hematopoietic cell lineages
[11]. In addition to its high expression in hematopoietic cells, Shp1
is expressed in epithelial cells including mammary epithelial and
breast cancer cell lines [12]. However, the role of Shp1 in the
growth and differentiation of mammary epithelial cells in vivo is still
not well understood. To explore the function of Shp1 in mammary
gland during puberty, pregnancy, and lactation we crossed the
Shp1 floxed mice [13] with the MMTV-Cre mice [5], in which
Cre is expressed in mammary epithelial cells of both virgin and
pregnant mice [6]. Surprisingly, we found that the MMTV-Cre
female mice displayed a lactation defect due to impaired lobular-
alveolar expansion and differentiation during pregnancy and early
lactation. We identified that the MMTV-Cre line in our study was
line A, which is one of the most widely used MMTV-Cre lines [6].
Analysis of integrated transgene revealed that the MMTV-Cre
transgene is physically linked to the cytokeratin 14 (K14)-agouti
transgene [14] in these mice. The results of our study indicate the
importance of using Cre mice alone as a control in any studies
involving the Cre-loxp recombination technology, and also suggest
that some MMTV-Cre lines are not appropriate for studies on
mammary gland development during pregnancy and lactation,
due to a profound lactation defect.
Results
Shp1 fl/+;MMTV-Cre and MMTV-Cre female mice have
severe lactation defect
To explore the role of protein tyrosine phosphatase Shp1 in
mammary gland development, we crossed mice bearing floxed
alleles (fl) of Shp1 [13] to the widely used MMTV-Cre mice [6] to
obtain the Shp1 fl/+; MMTV-Cre female mice. These mice were
then mated to Shp1 fl/+ male mice to generate Shp1 fl/
fl;MMTV-Cre female mice. The first litters born by all five of
the Shp1 fl/+/;MMTV-Cre female mice were of normal litter size.
Surprisingly, none of the pups nursed by the Shp1 fl/+;MMTV-
Cre dams gained weight normally over the first ten days of
lactation, and all of the pups in four of the five litters died by day
eighteen of lactation (L18). The dead pups all appeared to be
significantly smaller when compared to pups nursed by normal
dams at the same stage of growth. One litter of 8 pups survived
until L18; however, the average weight of these pups was 3.9
grams regardless of the genotype or sex of the pup, compared to
more than 10 grams observed in normal pups nursed by normal
dams at L18. The lack of pup growth during lactation was
exhibited by all pups regardless of their sex or genotype, and
suggested to us that the Shpi1fl/+;MMTV-Cre dams must display
a lactation defect [15].
To further verify that the Shp1 fl/+;MMTV-Cre dams
displayed a lactation defect, age-matched virgin Shp1 fl/+;
MMTV-Cre female mice and control Shp1 fl/+ female mice
were mated with wild type male mice. At L1, both pup and litter
sizes appeared to be the same for both the Shp1 fl/+;MMTV-Cre
and Shp1 fl/+ dams. Litter size was normalized to six pups per
dam as a means to provide equal demand on the mammary gland
during lactation, and the pups were then weighed at L5, L8, and
L10. Consistent with our initial observation, the weights of the
pups nursed by the Shp1 fl/+;MMTV-Cre dams were significantly
reduced by 50% or more compared to the weights of control
litters, at L5, L8, and L10 (Figure 1). As a second control we also
included analysis of litters nursed by MMTV-Cre dams (Figure 1).
The weights of pups nursed by MMTV-Cre dams were identical
to that observed with pups nursed by the Shp1 fl/+;MMTV-Cre
dams; pups nursed by MMTV-Cre dams were 50% smaller than
pups nursed by Shp1fl/+ dams at all time points examined.
Although the MMTV-Cre mice used in this study were young
adults, we have also observed that 6-month-old MMTV-Cre
female mice are unable to support the normal growth of their pups
(data not shown), suggesting that this lactation defect was not the
result of delayed ductal development during puberty. These data
indicate that dams carrying the MMTV-Cre transgene exhibit a
profound lactation defect.
To further characterize the lactation defects and determine
when they occurred during mammary gland development and
remodeling, we analyzed the histology of the number four
mammary gland at different developmental stages from the
Shp1 fl/+;MMTV-Cre, MMTV-Cre, and Shp1 fl/+ female mice.
Figure 1. Shp1 fl/+;MMTV-Cre and MMTV-Cre display a
lactation defect. Shp1 fl/+ (control), Shp1 fl/+;MMTV-Cre, and
MMTV-Cre female mice were mated with wild type FVB male mouse.
On the first day following parturition, the litter size was normalized to 6
pups/litter. Pups were weighted at lactation days 5, 8, and 10. The
average weight of each litter is shown and bars indicate the standard
deviation (SD). ** indicates P,0.001. The data shown is representative
of at least two independent experiments.
doi:10.1371/journal.pone.0019233.g001
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from the 10-week old virgin mice. Compared to the Shp1 fl/+
control gland, the mammary glands from both Shp1 fl/+;MMTV-
Cre and MMTV-Cre mice showed grossly normal ductal
elongation, growth and side branching (Figure 2A). We also
conducted histological examination of hematoxylin and eosin
stained thin sections of the mammary glands from these three lines
of mice, during pregnancy and lactation. At pregnancy day 15
(P15) the density of mammary alveoli are similar in the mammary
glands from all three lines of mice (Figure 2B). However, when
these sections are examined under higher magnification, the
mammary epithelial cells in alveoli from the Shp1 fl/+ control
mice were noted to contain numerous large cytoplasmic lipid
droplets (CLDs). In contrast, mammary alveolar epithelial cells in
the Shp1 fl/+;MMTV-Cre and the MMTV-Cre mice have
decidedly fewer and smaller CLDs at P15 (Figure 2C). At L1, the
lumina of the mammary alveoli from both the Shp1 fl/+;MMTV-
Cre as well as and the MMTV-Cre mice had not expanded, and
the epithelial cell layer appears to be thinner. The presence of
larger mammary adipocytes in mammary glands of both the Shp1
fl/+;MMTV-Cre and MMTV-Cre mice makes it hard to
determine whether there are fewer alveolar structures or not
(Figure 2B and C). In addition, although the CLDs in the
mammary epithelial cells from the Shp1fl/+ mice are small, which
is typical of a mouse that has undergone secretory activation, the
CLDs in the mammary epithelial cells from both the Shp1 fl/+;
MMTV-Cre and the MMTV-Cre mammary glands were larger
(Figure 2C). The presence of large CLDs in mammary epithelial
cells and the absence of expanded luminal space suggest that the
secretory activation has not occurred completely [16].
By L10, the mammary glands from the Shp1fl/+ mice are
completely filled with the fully expanded secretory alveoli
(Figure 2B), with evidence of milk secretion as exemplified by
proteinaceous material in the luminal space (Figure 2C), and the
near absence of mammary adipocytes (Figures 2B and C). In
contrast, the mammary glands from both the Shp1 fl/+;MMTV-
Cre and MMTV-Cre dams still contained a large portion (,50%)
of mammary adipocytes that are readily apparent even at L10
(Figure 2B). Furthermore, detached epithelial cells, which are
likely apoptotic cells, were readily apparent at L10 in the luminal
space of secretory alveoli from both Shp1 fl/+;MMTV-Cre and
the MMTV-Cre mice (Figure 2C). Results from cleaved caspase3
immunostaining confirm that the numbers of apoptotic cells in the
L10 mammary glands are increased dramatically in Shp1 fl/+;
MMTV-Cre and MMTV-Cre dam compared to control dams
(Figure 2D and 2E). These data strongly suggest that the Shp1
fl/+; MMTV-Cre and MMTV-Cre female have defects in
secretory activation and functional differentiation of luminal
epithelial cells, resulting in the early onset of involution even
when the pups are being nursed by these dams. This precocious
induction of involution likely further contributes to the observed
lactation defect.
Abnormal activation of Stat5 and Stat3 in the mammary
glands of mice expressing the MMTV-Cre transgene
Stat5 activation is required for the proliferation and differen-
tiation of mammary epithelial cells during pregnancy and lactation
[17], while activation of Stat3 is required for mammary gland
involution [18]. Therefore we examined the activation of both
Stat5 and Stat3 by immunoblotting mammary gland lysates from
Shp1fl/+, Shp1 fl/+;MMTV-Cre, and MMTV-Cre mice with
antibodies that recognize the phosphorylated, activated forms of
each Stat protein (Figure 3). At P15, activation of Stat5, as
indicated by phosphorylation of tyrosine 694 (Y694), was similar in
glands from Shp1fl/+, Shp1 fl/+;MMTV-Cre and MMTV-Cre
mice. At L1 robust phosphorylation of Stat5 was observed in the
mammary glands from Shp1fl/+ mice (Figure 3, top panel, lane 1),
however, phosphorylation of Stat5 was significantly reduced in the
mammary glands from Shp1 fl/+;MMTV-Cre and MMTV-Cre
mice (Figure 3, top panel, lanes 2 and land 3). At L10,
phosphorylation of Stat5 was robust in Shp1fl/+ mammary
glands, whereas phosphorylation of Stat5 remained reduced in
glands from Shp1 fl/+;MMTV-Cre and MMTV-Cre mice.
Conversely, at both L1 and L10, activation of Stat3 was prominent
in mammary glands from both Shp1 fl/+;MMTV-Cre (Figure 3,
second panel, lane 2) and MMTV-Cre mice (lane 3), compared to
the amount of phosphorylated Stat3 in control glands from
Shp1fl/+ mice (lane 1). Interestingly, the level of phosphorylated
Stat3 observed in the mammary glands from Shp1 fl/+;MMTV-
Cre and MMTV-Cre mice at L1 and L10 is comparable to that
observed in mammary glands from wild type FVB mice on
involution day 2 (lane 4). Thus, both the histological and
biochemical data strongly suggest that the MMTV-Cre female
mice have impaired functional differentiation of mammary
epithelial cells, which when coupled with an early onset of
mammary involution, explains why dams that carry the MMTV-
Cre transgene are unable to lactate normally. Furthermore these
data suggest that the lactation defect observed in the Shp1
fl/+;MMTV-Cre female is not due to the 50% decrease in Shp1
protein expression, but rather due to changes associated with the
presence of the MMTV-Cre transgene.
MMTV-Cre transgene is physically linked to the K14-
agouti cassette
The defect in secretory activation and lactation in the MMTV-
Cre female mice, developed by the Hennighausen laboratory [5],
has not been previously reported in the literature, nor have such
developmental defects been described in MMTV-Cre mice
developed by the Muller laboratory [7]. Although toxic effects of
elevated Cre recombinase expression have been reported [4], we
also considered whether there were features unique to the
MMTV-Cre lines used in our studies that might underlie the
observed lactation defect. One possible explanation is that the
lactation defect in this line of MMTV-Cre mice could result from
the integration of the MMTV-Cre transgene into a gene critically
important for mammary epithelial differentiation, secretory
activation, or lactation. To address this possibility, we decide to
clone the integration site for the MMTV-Cre transgene using the
inverse PCR [19] as outlined in Figure 4A. Briefly, this method
involves digestion of genomic DNA with restriction enzymes,
followed by ligation of the digested genomic DNA to generate
circular DNA molecules. The circular DNAs are subjected to two
rounds of PCR amplification using two pairs of nested primers
[rabbit growth hormone intron sequence (RGI)-1F/RGI-1R and
RGI-2F/RGI-2R] located in the MMTV-Cre transgene
(Figure 4A and B) (See Table 1 for primer sequences). Sequencing
the DNA product from the second round of PCR amplification
should yield information regarding the DNA sequences that are
linked to the MMTV-Cre transgene in the mouse genome, and
thus represent the integration site.
Sequence analysis of the initial PCR product obtained from the
inverse PCR reaction revealed that the MMTV-Cre transgene was
physically linked to a DNA fragment that included the K14
promoter linked to the agouti gene, followed by the poly A
addition signal from the 39end of the human growth hormone
gene. This sequence was identical to the transgene termed the
K14-agouti cassette originally described by Kucera et al [14]. This
result was surprising because there was no mention of the use of
MMTV-Cre Line A Mice Has Lactation Defect
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transgene. (A) The number 4 mammary glands from Shp1 fl/+ (control), Shp1 fl/+/;MMTV-Cre, and MMTV-Cre mice were isolated from 10-week old
virgin mice and subjected to whole mount analysis as described in the Materials and Methods. Scale bar=5 mm. (B, C) Six-week old Shp1 fl/+
(control), Shp1 fl/+;MMTV-Cre, and MMTV-Cre female mice were mated with male wild type mice. The number 4 mammary glands were removed at
pregnancy day 15 (P15), lactation day 1 (L1), and day 10 (L10), and processed for histological analysis as described in the Materials and Methods.
Images were taken under lower (B) and higher (C) magnification respectively. Scale bars represent 100 mm in (B) and 50 mm in (C). Similar results were
seen from at least two different mice for each genotype. (D, E) Analysis of apoptotic cells in L10 mammary glands as described in (B, C). (D) Sections of
L10 mammary glands from indicated mice were stained with antibody against cleaved caspase 3 (see Materials and Methods). Cells positive for
cleaved caspase 3 are stained dark-brown. Images were taken using 40X objective lens. Scale bar=50 mm. (E) Quantification of caspase 3 positive
cells from (D) (see Materials and Methods). Two mice from each genotype were analyzed. **p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0019233.g002
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generation of the MMTV-Cre mice [5]. We have recently
discovered however, that the K14-agouti transgene was co-
injected with the MMTV-Cre DNA to facilitate the identification
of mice that displayed germ line integration of the transgene, since
these mice display light yellow fur color in the background of black
fur (L. Hennighausen, personal communication). Repeating the
same approach by using two pairs of nested primers located in
K14 agouti cassette confirmed these data and revealed that the
DNA adjacent to the K14-agouti transgene was the MMTV-Cre
transgene. No other mouse genomic DNA sequences were found
after these two rounds of inverse PCR. These results suggest
strongly that multiple MMTV-Cre cassettes are ligated to multiple
K14-agouti cassettes in an alternating fashion. PCR analyses,
using different PCR primer pairs that include one primer in the
MMTV-Cre cassette and the other primer in the K14-agouti
cassette, revealed that the MMTV-Cre cassette is ligated to the
K14-aguoti cassette in a head-to-tail and tail-to-tail fashion
(Figure 4B).
Three independent MMTV-Cre lines (A, D, and F) were
initially generated by the Hennighausen lab [5] and they have
been used in various studies of the mammary gland. Line A and
line D [6,20] are the more widely used founder lines in comparison
to the number of studies that have utilized founder line F [21]. To
confirm which MMTV-Cre line was used in our study, we
performed PCR analysis using primer pairs that can distinguish
the head-to-tail [MMTV-1R/human growth hormone polyade-
nylation sequence (GHA)-1R primer set] and tail-to-tail (RGI-1F/
GHA-1R primer set) linkage of the MMTV-Cre and the K14-
agouti cassettes (Figure 4B). We determined that the MMTV-Cre
line used in our studies was line A because genomic DNAs from
our MMTV-Cre line (Figure 4, lane 2), the MMTV-Cre line A
from the Jackson laboratory (figure 4, lane 3), and a recently
obtained DNA sample of line A from the Hennighausen lab
(Figure 4, lane 5) all contain both the head-to-tail and tail-to-tail
linkages. In contrast, genomic DNAs from line D (obtained from
Jackson Laboratory) (Figure 4, lane 4) and line F (obtained from
the Hennighausen lab) (Figure 4, lane 6) contain only the tail-to-
tail linkage of the MMTV-Cre and the K14-agouti cassettes
(Figure 4B). Interestingly, the PCR product of the tail-to-tail
linkage from Line D (Figure 4B Bottom panel, lane 4) is ,50 bp
smaller than those products from Line A (lane 2,3,5) and Line F
(lane 6). DNA sequencing confirms that the PCR product of the
tail-to-tail linkage from Line D lacks 12 bp sequence in the 39 end
of the rabbit growth hormone intron (RGI) sequence and 40 bp
sequence in the 39end of the human growth hormone polyade-
nylation (GHA) sequence. Thus, by performing PCR analysis on
genomic DNA using the two primer sets (MMTV-1R/GHA-1R
for head-to-tail and RGI-1F/GHA-1R for tail-to-tail) (see Table 1
and Figure 4B), MMTV-Cre line A, D, and F can be distinguished
from each other. Both the MMTV-Cre line A and line D mice
available from the Jackson laboratory were originally donated by
the Hennighausen lab. The MMTV-Cre line F generated by the
Hennighausen lab is only available from the Mouse Models of
Human Cancer Consortium.
Discussion
These studies were initially undertaken to examine the role of
Shp1, a protein tyrosine phosphatase, in mammary gland
development. The observation that mice containing a single allele
of Shp1 displayed a lactation defect (Figure 1) was of great interest
since we did not anticipate that a 50% decrease in Shp1 protein
expression in mammary epithelial cells would have such a
dramatic effect. A careful review of the Shp1 literature, however,
strongly suggested that this conclusion may not be correct. The
naturally occurring Shp1 mutation observed in the motheaten (me)
mice was discovered in 1975 [22], and heterozygous Shp1
me/+
mice express only 50% of the Shp1 protein in all tissues. Shp1
me/+
mice female mice are healthy, and no lactation defects have been
reported or observed in Shp1
me/+ female mice [22]. The absence of
a lactation defect in the Shp1
me/+ mice caused us to conclude that it
was more likely that the MMTV-Cre transgene contributing to the
lactationdefectinthesemiceratherthan loweramounts oftheShp1
protein. Unfortunately, the original paper describing the generation
of the MMTV-Cre mice did not mention whether the MMTV-Cre
female mice lactated normally [5].
In this study, we demonstrate that the MMTV-Cre line A mice
[5], have a severe lactation defect. The defect is associated with
reduced lobular-alveologenesis during pregnancy, impaired secre-
tory activation as revealed by large cytoplasmic lipid droplets
within mammary epithelial cells postpartum and the early onset of
involution of mammary glands during early lactation. The
MMTV-Cre line A has been widely used to study gene function
in the mammary gland during pregnancy and lactation
[23,24,25,26] or tumorigenesis [27,28]. The fact that the line A
mice were used in these studies led us to assume that the lactation
status of MMTV-Cre line A had been examined and determined
Figure 3. Changes in the activation of Stat5 and Stat3 in
mammary glands from mice expressing the MMTV-Cre trans-
gene during late pregnancy and early lactation. The number 4
mammary glands from Shp1 fl/+ (control) (lane 1), Shp1 fl/+;MMTV-Cre
(lane 2), and MMTV-Cre (lane 3) mice at pregnancy day 15 (P15),
lactation day 1 (L1), day 10 (L10), and from wild type FVB mice at
involution day 2 (I2) (lane 4) were isolated and whole tissue lysates
prepared as described in the Materials and Methods. Equal amount of
proteins (,40 mg) from each sample were resolved by gel electropho-
resis, and immunoblotted with antibodies against phospho-Stat5
(p-Stat5; Y694), or phospho-Stat3 (p-Stat3; Y705). The immunoblots
were reprobed with antibodies against Stat5, Stat3, and cytokeratin-18
(CK-18), and beta-actin to demonstrate equal loading. Similar results
were seen from at least two different mice for each genotype.
doi:10.1371/journal.pone.0019233.g003
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MMTV-Cre lines generated by Wagner et al [5] indicate that the
lactation status of these mice (line A, D, and F) has never been
specifically described. Most importantly, our review of the studies
that have utilized these MMTV-Cre lines indicated that either
wild type mice or mice that were homozygous for the floxed alleles
were generally used as the control mice. Based on our findings in
this paper, it is important to re-examine conclusions drawn from
previous studies using the MMTV-Cre line A mice [23,24,25,26].
In addition, it is also important to examine whether MMTV-Cre
lines D and F have lactation defects similar to what we have found
in the line A mice. The situation is further confused by the fact that
Figure 4. Identification of the linkage of the K14-Agouti cassette to the MMTV-Cre transgene using inverse PCR. (A) The schematic
diagram of the inverse PCR. (B) PCR using specific primer sets identified the K14-agouti cassette adjacent to the MMTV-Cre transgene. The linkage of
the linkage of the MMTV-Cre and K14-agouti transgenes allow distinction of the line A, line D and line F founder lines. The MMTV-Cre cassette [5] also
contains a rabbit growth hormone intron sequence (RGI). The K14-Agouti cassette [14] also contains a human growth hormone polyadenylation
sequence (GHA). The Cre-F/Cre-R primer set identifies the presence of Cre gene. The K14P-3R/GHA-1F primer set identifies the presence of the K14-
agouti cassette. The MMTV-1R/GHA-1R primer set identifies the presence of the head-to-tail linkage of the K14-agouti cassette and the MMTV-Cre
cassette. The RGI-1F/GHA-1R primer set identifies the presence of the tail-to-tail linkage of the MMTV-Cre cassette and the K14-agouti cassette. 1, wild
type DNA; 2, MMTV-Cre DNA used in this study; 3, MMTV-Cre line A DNA from Jackson lab; 4, MMTV-Cre line D from Jackson lab; 5, MMTV-Cre line A
DNA from Hennighausen lab; 6, MMTV-Cre line F DNA from Hennighausen lab; N, no DNA control. Note, lane 2, 3, and 5 (all Line A) have the same
PCR fragments for the head-tail and the tail-tail linkages whereas lane 4 (line D), and lane 6 (line F) only have PCR fragments for the tail-tail linkage.
The sizes of PCR products are listed under each DNA gel panel.
doi:10.1371/journal.pone.0019233.g004
MMTV-Cre Line A Mice Has Lactation Defect
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of the MMTV-Cre mice was utilized. It is possible that some
authors may not recognize the differences among different
MMTV-Cre lines generated by the Hennighausen laboratory
[21,29,30,31,32]. The strategy that we have used to clone the
integration site for the MMTV-Cre transgene has resulted in a
PCR genotyping method that allows one to distinguish among the
A, D, and F lines of the MMTV-Cre mice (Figure 4B), and this
can be used to establish the identity of the lines in these published
studies. In addition to the MMTV-Cre lines established by the
Hennighausen laboratory, two other laboratories have generated
independent MMTV-Cre lines [7,8]. Both of these other lines
show relatively specific deletion of the floxed genes in mammary
epithelial cells; however, only Boussadia et al specifically stated that
mammary gland development was normal during pregnancy and
lactation [7,8].
It is not clear why the MMTV-Cre line A dams display a
lactation defect, and there are several possibilities could potentially
explain this phenotype. First, the genetic background of the mice
could play a role. The MMTV-Cre line A mice used in our studies
had been backcrossed onto the FVB background more than 9
generations. The agouti locus was used as a marker for transgene
integration in mice that have a black coat color such as C57BL6;
the original MMTV-Cre mice were generated on the C57BL6
genetic background. A review of the literature indicates that the
majority of published studies using the MMTV-Cre line A mice
predominantly utilized mice on a mixed genetic background (i.e.
mixture of two or three backgrounds such as C57BL6, 129Sv, and
FVB) [23,24,25,26]. Thus, it is possible that an allele important for
lactation on the FVB background could result in the appearance of
the lactation defect in MMTV-Cre line A mice only on this genetic
background. While this manuscript was in preparation, a study by
the Hennighausen lab indicated that MMTV-Cre line A mice on
mixed genetic background comprising the 129Sv and C57BL6
strains also have a lactation defect [33]. In this study, pups nursed
by line A dams weighed only ,40% of controls at L15 [33].
Therefore, it is unlikely that the lactation defect described in our
study is specific to mice on the FVB background. Second, the
MMTV-Cre line A mice may express exceptionally high levels of
Cre recombinase in the mammary gland during pregnancy, and it
has been reported that acute high expression of Cre in mammary
cells can inhibit cell growth via non-specific excision of DNA by
Cre recombinase [4]. We think that this possibility is unlikely
because our preliminary data show that the level of Cre mRNA
expression in the pregnant mammary glands from our MMTV-
Cre line A and BLG-Cre mice appears to be similar (data not
shown), and BLG-Cre female mice do not exhibit a lactation
defect [34]. Third, the integration of the MMTV-Cre transgene
into the mouse chromosome may disrupt a gene important for
lobuloalveolar growth and differentiation. Our inverse PCR
studies were designed to identify the integration site for the
transgene in the line A mice as described in Figure 4, however this
approach revealed that the MMTV-Cre transgene is actually
linked to the K14-agouti cassette in a repeated fashion, which
limited our ability to identify the genomic integration site for the
MMTV-Cre transgene. Finally, the presence of the K14-agouti
cassette could also poise a potential problem in either mammary
gland development or secretory activation. The product of the
Agouti gene has been reported to inhibit lipolysis in human
adipocytes [35], and thus expression of the K14-agouti cassette
could potentially inhibit lipolysis in the mammary gland, or
alternatively modify lipid biosynthesis in mammary epithelial cells
resulting in the described lactation defect. Resolution of these
different alternatives will require more extensive investigation and
is likely to yield interesting results.
In conclusion, we find unexpectedly that MMTV-Cre line A,
one of the three widely used MMTV-Cre transgenic mouse lines
generated by the Hennighausen laboratory, exhibits a severe
lactation defect. The existence of this lactation defect argues
against using the MMTV-Cre line A mice to study gene function
in mammary gland during pregnancy and lactation. In addition,
we uncovered that the MMTV-Cre transgene is physically linked
to the K14-agouit transgene in all of these MMTV-Cre mouse
lines generated by the Hennighausen laboratory [5,6]. Using this
information, we have developed a PCR-genotyping method that
allows these three different founder lines of MMTV-Cre mice to
be readily distinguished. A recent study indicates that MMTV-Cre
line D mice have a minor lactation defect, and that the MMTV-
Cre line F mice have a more severe lactation defect than line A
mice analyzed in the same study [33]. We advise researchers to
take extreme caution when using one of these MMTV-Cre
founder lines [5,6] in their studies if they intend to evaluate
secretory activation and/or lactation. It should also be readily
apparent that mice expressing the MMTV-Cre transgene alone
must be used as a control for all studies.
Materials and Methods
Ethical Statement
All animals were handled in accordance with protocols for the
humane treatment of animals. This study was approved by the
University of Colorado Denver Institutional Animal Use and Care
Committee.
Mice
MMTV-Cre mice (A) mice (mixed C57BL/6 and Sv129 genetic
background) were obtained from L. Hennighausen (NIH) (Wagner et
al 1997), and were backcrossed onto FVB background for more than
9 generations prior to use. Genotyping was conducted using primers
as described (Wagner et al 1997). Male MMTV-Cre mice were
mated with female FVB mice during backcrossing and strain
maintenance. Shp1 floxed (fl) mice [13] were backcrossed onto
FVB background for more than 9 generations. The primers for
genotyping Shp1 floxed (fl) mice include SHCP 27 (59-AC-
CCTCCAGCTCCTCTTC-39), SHCP 29 (59-TGAGGTCCCGG-
TGAAACC-39), and SHCP 32 (59-TGTTATGCATGTGTG-
TATCG-39). The primer set, Cre-F and Cre-R, was used to
genotype the MMTV-Cre mice (see Table 1 for sequence
Table 1. Primers used for inverse PCR and genotyping the
MMTV-Cre mice.
Primer Sequence (59–39)
RGI-1F GGTTGTTGTGCTGTCTCATC
RGI-1R CACGTTGCCCAGGAGCTGTA
RGI-2F GAAGCCCCTTGAGCATCTGA
RGI-2R CCCGGTTTGGACTCAGAGTA
MMTV-1R AGAGGAAGTTGGCTGTGGTC
Cre-F ATGTCCAATTTACTGACCG
Cre-R CGCCGCATAACCAGTGAAAC
GHA-1F CCCTACAGGTTGTCTTCCCA
GHA-1R TGCTGGGATTACAGGCGTGA
K14P-3R GGACCAAGTGGACTCCTAGAAATG
doi:10.1371/journal.pone.0019233.t001
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mice used in this study were hemizygous for the MMTV-Cre
transgene. Mice were maintained in the Center for Comparative
Medicine at the University of Colorado, Anshutz Medical Campus,
an AAALAC-approved facility, and provided chow and water ad
libitum.
Quantitation of lactation competency
Lactation day 1 (L1) was defined as the day upon which pups
were born. All litters from the Shp1 fl/+ (control), Shp1 fl/+;
MMT-Cre, and MMTV-Cre dams were normalized to 6 pups/
litter for each nursing dam on L2. Pups in each normalized litter
were weighted at L5, L8, and L10. The average weight of each
litter was determined and plotted versus the day of lactation; this
method has been used to accurately determine the lactation
competency of lactating dams [15,36]. The significance of the pup
weight difference was determined by analysis using unpaired
student Two-tailed t-test.
Antibodies and reagents
Antibodies to phosphorylated Stat3 (Y705) and phosphorylated
Stat5 (Y694) were purchased from Cell Signaling (Beverly, MA).
Rabbit polyclonal antibodies to Stat3 and Stat5 were from Santa
Cruz Biotechnology (Santa Cruz, CA). Guinea Pig polyclonal
antibodies to cytokeratin-8/18 were from Fitzgerald Industries
International (www.fitzgerald-fii.com). Anti-beta-actin mouse
monoclonal antibody was from Sigma Chemical Company.
Restriction enzymes and modification enzymes T4 DNA poly-
merase, T4 DNA ligase and Phire Hot Start DNA polymerase
were from New England Biolab (Ipswich, MA). SignalStain
TM
Cleaved Caspase3 (Asp175) Immunohistochemistry (IHC) detec-
tion kit was purchased from Cell Signaling (Beverly, MA). DNA
primers were synthesized by Invitrogen. Genomic DNAs for
MMTV-Cre line A and MMTV-Cre line D were purchased from
Jackson Laboratory (Bar Harbor, Maine). Recently prepared
genomic DNAs for MMTV-Cre line A and line F were also kindly
provided by Drs. G.W.Robinson and L. Hennighausen (NIH).
Analysis of mammary gland histology and apoptosis
The number 4 mammary glands were dissected and fixed
overnight in 10% neutral buffered formalin. The fixed mammary
tissue was embedded in paraffin, 4 mm sections prepared, and
stained with hematoxylin and eosin by the Pathology Core
Laboratory at University of Colorado Cancer Center. For whole-
mount analysis, the dissected mammary glands were placed in
histology cassettes, and fixed overnight in 10% neutral buffered
formalin. The fixed mammary glands were defatted in acetone (3
washes, one hour/wash), rehydrated through graded alcohols, and
stained overnight with carmine alum solution (0.2% carmine,
0.5% aluminum potassium sulfate in distilled water). The whole
mounts were then rinsed in running water, rinsed in acidic 50%
ethanol (pH 1.25), dehydrated in graded ethanols, prior to placing
in xylene. Stained glands were mounted with Permount (Fisher
Scientific). Apoptotic cells in mammary glands from lactation day
10 mice were quantitated by staining thin sections with the cleaved
caspase3 IHC detection kit (Cell Signaling) according to the
manufacturer’s protocol. Cleaved caspase3 positive cells were
quantified by counting caspase3-stained cells in ten high-power
fields (40 x objective lens) with equivalent density of mammary
epithelial cells. The average number of caspase3 positive cells per
40 x field is used for comparison +/- standard deviation.
Mammary glands were analyzed from two individual mice for
each genotype.
Biochemical analysis of mammary glands
Number 4 mammary glands were dissected, flash frozen in
liquid nitrogen, and the tissue disrupted by sonication with a
Polytron (Brinkmann Instruments) in mammary gland lysis buffer
[(50 mM Tris pH 7.4, 150 mM NaCl, 2 mM EDTA, 50 mM
NaF, 1% Triton X-100, 1% DOC, 0.1% SDS, 1 mM DTT,
5 mM sodium orthovanadate, supplemented with 100 mg/ml
PMSF, and Complete protease inhibitor cocktail (Roche Applied
Sciences, Indianapolis, IN)]. Lysates were clarified by centrifuga-
tion and soluble protein concentration was measured by Bradford
method. Equal amounts of protein samples were resolved by SDS-
PAGE, transferred to Immobilon-P membrane (Millipore Inc.),
immunoblotted using the appropriate primary and secondary
antibodies, and immunoreactive bands detected by enhanced
chemiluminescence.
Identification of the K14-agouti cassette linked to MMTV-
Cre transgene by Inverse PCR
Livers from wild type and MMTV-Cre mice were digested in
buffer containing 2 mg/ml protease K, 10 mM Tris pH 8.0,
25 mM EDTA, 0.5% SDS, 100 mM NaCl at 55uCo v e r n i g h t .
DNA was extracted with Phenol/Chloroform, ethanol precip-
itated, and resuspended in distilled water. Purified genomic
DNAs were digested with restriction enzymes and blunt-ended
fragments generated by treatment with T4 DNA polymerase,
after which circular DNA molecules were generated by self-
ligation with T4 DNA ligase for use as templates for inverse
PCR. After 1
st round PCR amplification using the primer set
RGI-1F/RGI-1R and the Phire Hot Start DNA polymerase, the
product was diluted 100-fold and used as template in 2
nd round
nested PCR amplification using the primer set RGI-2F/RGI-
2R. The amplified PCR products were purified for sequencing.
Most of the PCR products were generated by amplification of
tandem repeats of the MMTV-Cre transgene. To identify PCR
products that included the human growth hormone polyA
addition signal present in the K14-Agouti transgene, genomic
DNA was digested with combinations of HincII/KpnI or
HincII/XbaI prior to PCR amplification [14]. The MMTV-
1R/GHA-1R primer set was used to identify the head-tail
linkage of the MMTV-Cre and the K14-agouti cassettes. The
RGI-1F/GHA-1R primer set was used to identify the tail-tail
linkage of the MMTV-Cre and the K14-agouti cassettes.
TheK14P-3R/GFA-1F primer set was used to identify the
presence of the K14-agouti cassette. The sequences of all
p r i m e r su s e di nt h i ss t u d ya r el i s t e di nT a b l e1 .
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